Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New PARP-1 inhibitors synthesized in China

March 19, 2012

Prostaglandin E2 derivative shows therapeutic potential in preclinical and clinical studies

March 19, 2012

Aileron Therapeutics reports new candidate cancer therapies

March 19, 2012

New PI3Kalpha and mTOR inhibitors designed in Spain

March 19, 2012

Novel p53-based peptidomimetics developed at Aileron Therapeutics

March 16, 2012

OncoSec begins enrollment at two new sites for metastatic melanoma trial

March 16, 2012

New apoptosis inducers divulged

March 15, 2012

Millennium Pharmaceuticals designs novel PI3K and mTOR inhibitors

March 15, 2012

Threshold Pharmaceuticals treats first patient in multiple myeloma study

March 15, 2012

Epizyme achieves preclinical milestone in mixed-lineage leukemia

March 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...